New RFA From the UC Heart, Lung and Vascular Institute
The HLVI 2017 Near Horizons Clinical Research Grant Program is accepting new proposals. This program is dedicated to important clinical problems in the field of cardiovascular or pulmonary medicine. Letters of Intent are due December 9, 2016, and full proposals are due February 17, 2017.
Although a clinical focus in cardiology, vascular or pulmonary medicine is required, this competition is open to all UC faculty, residents, clinical fellows and post-doctoral fellows. The HLVI encourages applications that include interactions between clinicians and population scientists to develop investigations for patients with serious diseases and chronic illnesses. Interdisciplinary collaborations between researchers from other UC colleges and affiliates are encouraged.
For more information, please contact Laura Hildreth at (513) 558-1057 or hildrele@uc.edu.
Tags
Related Stories
Cancer Center plays key role in lab research, clinical trials for new pancreatic cancer drug
September 1, 2026
WLWT and WCPO highlighted the contributions of University of Cincinnati Cancer Center researchers that helped lead to the recent FDA approval of daraxonrasib, a new treatment for pancreatic cancer.
Cancer Center physician receives $150,000 New Investigator Research Grant to study treatment-resistant leukemia
September 1, 2026
The University of Cincinnati Cancer Center’s Sarah Skuli, MD, PhD, received a two‑year, $150,000 Leukemia Research Foundation New Investigator Grant to study TP53‑mutated leukemia, a treatment‑resistant subtype with very poor outcomes.
Heavy social media use linked to depression
August 31, 2026
U.S. News and World Report, Yahoo! News, MSN, USA Today and other national media highlight a new study by the University of Cincinnati and Northwestern University that found a correlation between heavy social media use and depression in adults.